INTEGRITY Committing to honesty, humility, and consistency in all that we do
Their broad effectiveness, safety, and expanding applications herald a new era in metabolic and related disorder management, unmatched by other therapies
It directly addresses the metabolic signaling dysfunction that drives those symptoms
No participants withdrew due to side effects related to the peptide
In 2024 Lilly announced $5.3 billion in its manufacturing site in Lebanon, Indiana, US
The question of whether semaglutide directly causes pancreatitis remains an area of ongoing investigation, with current evidence suggesting a possible association rather than a confirmed causal relationship